Church & Dwight (CHD) Consumer Analyst Group of New York Conference (CAGNY ) 2025 summary
Event summary combining transcript, slides, and related documents.
Consumer Analyst Group of New York Conference (CAGNY ) 2025 summary
8 Jan, 2026Leadership transition
Matt Farrell will step down as CEO on April 1st, with Rick Dierker, current CFO and Head of Business Operations, succeeding him.
The transition is positioned as seamless, with both leaders emphasizing continuity and execution-focused culture.
2024 performance highlights
Achieved 4.6% organic sales growth in 2024, with five of seven Power Brands gaining market share.
Innovation drove 50% of total growth, and online sales surpassed 21% of revenue.
International expansion included Hero and TheraBreath brands in 40+ countries and a distributor acquisition in Japan.
Generated $1.16B in cash from operations, ending with $960M cash on hand and a leverage ratio of 1.5.
Total company net sales reached $6.1B, with 77% domestic, 18% international, and 5% specialty products.
Financial performance and outlook
FY 2025 guidance: 3–4% organic growth, 60–70 bps operating margin expansion, 7–8% EPS growth, and $1.1B+ cash flow.
10-year average net sales growth is 6.5%, with consistent improvement in volume trends and gross margin.
Free cash flow conversion averages 119%, supported by strong working capital management and low leverage.
Strong balance sheet with $965M cash, $5.1B leverage capacity, and A3/BBB+ credit rating.
Dividend increased 4% in 2025, marking 124 consecutive years of dividends.
Latest events from Church & Dwight
- Key votes include director elections, executive pay, auditor ratification, and a written consent proposal.CHD
Proxy filing19 Mar 2026 - Board recommends all director nominees, pay, and auditor; opposes written consent proposal.CHD
Proxy filing19 Mar 2026 - 2026 targets 3–4% organic sales and 5–8% EPS growth, led by power brands and innovation.CHD
Consumer Analyst Group of New York Conference (CAGNY) 202618 Feb 2026 - Q2 sales, margins, and EPS beat expectations; growth slowed, but APAC and innovation advanced.CHD
Q2 20242 Feb 2026 - 2026 targets 3–4% organic sales growth and 5–8% EPS growth, led by innovation and portfolio focus.CHD
Q4 & Analyst Day 20261 Feb 2026 - 2024 outlook targets strong sales and EPS growth, fueled by innovation and global expansion.CHD
2024 dbAccess Global Consumer Conference31 Jan 2026 - Power brands, innovation, and disciplined M&A fuel growth across U.S. and international markets.CHD
Barclays 17th Annual Global Consumer Staples Conference22 Jan 2026 - Q3 organic growth and margin gains were offset by a $357.1M vitamin business impairment.CHD
Q3 202417 Jan 2026 - 2024 delivered strong growth and cash flow; 2025 targets further organic and EPS gains.CHD
Q4 & Investor Day 20249 Jan 2026